WHICH journals are RELEVANT to monitor for pharmacovigilance?
GVP says “The marketing authorisation holder should establish the most relevant source of published literature for each product.” (VI. App 2.2. Where to look).
How do we define what a ‘relevant source’ is? It is an open question because authorities do not specify the sources to be monitored and they do not give the definition of relevance either. It is left for MAHs to decide what ‘relevant’ means and which journals stand for it. But be careful how you answer the question! The most frequently applied principles are not in compliance with GVP. If you would like to read more on selection principle for journals, please refer to the schemes we have prepared below.
This post is the third in a series. We believe that answering basic questions on search in literature such as which drugs, when etc., can guide us in building an effective literature monitoring system in compliance with GVP. We are going to zoom into seven questions and share our experience how we have successfully answered them at ComFit. Stay tuned!